You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

HYDROXYZINE PAMOATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hydroxyzine Pamoate, and what generic alternatives are available?

Hydroxyzine Pamoate is a drug marketed by Barr, Beximco Pharms Usa, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, and Watson Labs. and is included in thirty-four NDAs.

The generic ingredient in HYDROXYZINE PAMOATE is hydroxyzine pamoate. There are nineteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydroxyzine pamoate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Hydroxyzine Pamoate

A generic version of HYDROXYZINE PAMOATE was approved as hydroxyzine pamoate by SANDOZ on December 31st, 1969.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDROXYZINE PAMOATE?
  • What are the global sales for HYDROXYZINE PAMOATE?
  • What is Average Wholesale Price for HYDROXYZINE PAMOATE?
Drug patent expirations by year for HYDROXYZINE PAMOATE
Drug Prices for HYDROXYZINE PAMOATE

See drug prices for HYDROXYZINE PAMOATE

Drug Sales Revenue Trends for HYDROXYZINE PAMOATE

See drug sales revenues for HYDROXYZINE PAMOATE

Recent Clinical Trials for HYDROXYZINE PAMOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shalvata Mental Health CenterN/A

See all HYDROXYZINE PAMOATE clinical trials

Pharmacology for HYDROXYZINE PAMOATE
Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Anatomical Therapeutic Chemical (ATC) Classes for HYDROXYZINE PAMOATE

US Patents and Regulatory Information for HYDROXYZINE PAMOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 086705-001 Jul 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 081165-001 Jul 31, 1991 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 087767-001 Aug 16, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 086698-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Barr HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088496-001 Jun 15, 1984 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

HYDROXYZINE PAMOATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Hydroxyzine Pamoate

Market Overview

The global hydroxyzine market, which includes hydroxyzine pamoate, is poised for significant growth driven by several key factors. Here are the critical market dynamics and financial projections for hydroxyzine pamoate.

Growth Projections

The hydroxyzine market is expected to grow at a compound annual growth rate (CAGR) of over 6.0% from 2024 to 2030, with some forecasts indicating a CAGR of 5.6% until 2034[1][4].

Market Size and Revenue

The global hydroxyzine industry size is forecast to reach USD 829.9 million in 2024 and is projected to rise to USD 1430 million by 2034. This substantial growth is driven by increasing demand for antihistamines and anxiolytic medications[4].

Key Drivers of Growth

Increasing Prevalence of Allergic Conditions

The rising incidence of allergic conditions such as atopic dermatitis, urticaria, and histamine-mediated pruritus is a major driver. For instance, atopic dermatitis affects up to 10% of adults and 20% of children, making it a significant health concern globally[1][3].

Anxiety Disorders

The growing prevalence of anxiety disorders also contributes to the demand for hydroxyzine. In the United States, around 40 million people experience an anxiety disorder each year, prompting a higher demand for medications like hydroxyzine[4].

Geriatric Population and Technological Advancements

The increasing geriatric population and advancements in healthcare technology are additional factors driving market growth. The geriatric population is more susceptible to conditions like insomnia, itching, and mental disorders, which hydroxyzine can treat[1][4].

Regional Market Analysis

North America

North America is expected to witness strong growth, driven by high awareness of treatments, robust healthcare infrastructure, and early adoption of novel medications. The United States, in particular, is anticipated to experience a CAGR of 5.9% during the assessment period, reaching USD 258.2 million by 2034[3][4].

Asia Pacific

The Asia Pacific region, especially countries like Japan and South Korea, is forecast to see robust growth. China's market is poised to advance at a CAGR of 6.3%, driven by an increasing geriatric population and surging demand for antihistamines[4].

Product Formulations and Preferences

Tablets and Extended-Release Formulations

Demand remains high for tablets due to their convenience, long shelf life, and ease of use. Extended-release formulations like hydroxyzine pamoate are also gaining popularity, allowing for less frequent dosing and maintaining therapeutic levels throughout the day[2][4].

Competitive Landscape

The hydroxyzine market is highly competitive, with major players like Teva Pharmaceuticals, Pfizer, Inc., and GSK, plc investing heavily in research and development. These companies are focusing on enhancing formulations, exploring new indications, and developing new delivery methods to maintain market share[4].

Regulatory and Marketing Strategies

Companies are navigating the regulatory landscape to ensure compliance with safety and efficacy standards. New marketing strategies, mergers, partnerships, acquisitions, and distribution agreements are becoming prevalent to expand market reach and customer base[4].

Challenges and Side Effects

While hydroxyzine pamoate has a generally favorable safety profile, it can have side effects such as constipation, confusion, dry mouth, and fatigue. Long-term use may lead to tolerance, dependence, cognitive impairment, weight gain, and rare cardiac effects[2][5].

Awareness and Research Investments

Campaigns to raise awareness about atopic dermatitis and other conditions treated by hydroxyzine are contributing to market growth. Significant investments in research, such as the USD 48 million allocated for atopic dermatitis research in 2022, are expected to drive innovation and demand for hydroxyzine imine drugs[3].

Key Takeaways

  • The global hydroxyzine market is expected to grow significantly, driven by the increasing prevalence of allergic conditions and anxiety disorders.
  • North America and the Asia Pacific region are key markets, with the United States and China showing strong growth potential.
  • Extended-release formulations like hydroxyzine pamoate are gaining popularity due to their convenience and therapeutic benefits.
  • Major pharmaceutical companies are investing in R&D and new marketing strategies to maintain market share.
  • Awareness campaigns and research investments are crucial for driving market growth.

FAQs

1. What are the primary uses of hydroxyzine pamoate?

Hydroxyzine pamoate is used to treat conditions such as hives, itching, dermatitis, and allergic skin reactions. It is also FDA-approved for short-term use to treat anxiety[5].

2. What is the expected market size of the hydroxyzine industry by 2034?

The global hydroxyzine industry size is projected to reach USD 1430 million by 2034[4].

3. Which regions are expected to see the most significant growth in the hydroxyzine market?

North America, particularly the United States, and the Asia Pacific region, especially Japan and South Korea, are expected to see robust growth[3][4].

4. What are the common side effects of hydroxyzine pamoate?

Common side effects include sleepiness, dizziness, skin reactions, dry mouth, fatigue, headache, constipation, and confusion[5].

5. How does the extended-release formulation of hydroxyzine pamoate differ from the immediate-release formulation?

The extended-release formulation of hydroxyzine pamoate has a longer half-life, allowing for less frequent dosing and maintaining therapeutic levels throughout the day, compared to the immediate-release formulation which requires multiple doses[2].

Cited Sources:

  1. Grand View Research - Hydroxyzine Market Size, Share And Growth Report, 2030
  2. California Prime Recovery - Hydroxyzine vs Xanax – Navigating the Differences, Uses, and ...
  3. Mordor Intelligence - Hydroxyzine Imine Market Size & Share Analysis - Growth Trends
  4. Future Market Insights - Hydroxyzine Market Size, Share, Trends & Forecast by 2034 | FMI
  5. Talkspace - Hydroxyzine Pamoate: Uses, Side Effects, Dosage - Talkspace

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.